Login / Signup

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Arrigo Francesco Giuseppe CiceroFederica FogacciAnca Pantea StoianMichal VrablikKhalid Al RasadiMaciej BanachPeter P TothManfredi Rizzo
Published in: Current atherosclerosis reports (2021)
A growing number of meta-analyses of randomized clinical trials supports the effectiveness and tolerability of some lipid-lowering nutraceuticals such as red yeast rice, plant sterols and stanols, soluble fibers, berberine, artichoke extracts, bergamot polyphenol fraction, garlic, green tea, and spiruline. No significant safety concern has been raised for the use of such products. Association of more lipid-lowering nutraceuticals and of some nutraceuticals with lipid-lowering drugs has been tested as well. Current evidence suggests that some clinically tested lipid-lowering nutraceuticals could be safely used to improve plasma lipid levels in subjects affected by mild-to-moderate dyslipidaemia with low cardiovascular risk.
Keyphrases
  • fatty acid
  • systematic review
  • randomized controlled trial
  • meta analyses
  • clinical trial
  • study protocol